"Aminocaproic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
| Descriptor ID |
D015119
|
| MeSH Number(s) |
D02.241.081.193.150.075 D12.125.213.075
|
| Concept/Terms |
Aminocaproic Acid- Aminocaproic Acid
- 6-Aminohexanoic Acid
- 6 Aminohexanoic Acid
- epsilon-Aminocaproic Acid
- epsilon Aminocaproic Acid
- 6-Aminocaproic Acid
- 6 Aminocaproic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aminocaproic Acid".
Below are MeSH descriptors whose meaning is more specific than "Aminocaproic Acid".
This graph shows the total number of publications written about "Aminocaproic Acid" by people in this website by year, and whether "Aminocaproic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aminocaproic Acid" by people in Profiles.
-
Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. Hematol Oncol. 2016 Sep; 34(3):147-53.
-
Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model. Blood Coagul Fibrinolysis. 2013 Jul; 24(5):489-97.
-
Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy. J Thorac Cardiovasc Surg. 2006 May; 131(5):963-8.
-
Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins. J Lipid Res. 2001 Dec; 42(12):2058-68.
-
Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neurooncol. 1994; 18(2):129-38.
-
Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid. J Cardiothorac Vasc Anesth. 1993 Aug; 7(4):431-5.
-
Antifibrinolytic therapy of experimentally grown malignant brain tumors. J Neurosurg. 1986 Feb; 64(2):263-8.
-
Intraoperative chemical hemostasis in neurosurgery. Neurosurgery. 1986 Feb; 18(2):223-33.
-
Monitoring of antifibrinolytic therapy following subarachnoid hemorrhage. The importance of CSF fibrin/fibrinogen degradation products. J Neurosurg. 1983 May; 58(5):699-707.